Edition:
United States

People: United Technologies Corp (UTX.N)

UTX.N on New York Stock Exchange

115.48USD
18 Aug 2017
Change (% chg)

$-0.62 (-0.53%)
Prev Close
$116.10
Open
$116.10
Day's High
$116.25
Day's Low
$115.36
Volume
907,403
Avg. Vol
764,153
52-wk High
$124.77
52-wk Low
$97.67

Garnier, Jean-Pierre 

Dr. Jean-Pierre Garnier, Ph.D., is an Independent Director of the Company. He is Chairman of Actelion Ltd. (biopharmaceuticals) and an Operating Partner at Advent International (global private equity). He served as CEO of Pierre Fabre SA from 2008 to 2010, and as CEO and Executive Member of the Board of Directors of GlaxoSmithKline plc from 2000 to 2008. He served as CEO of SmithKline Beecham plc in 2000 and as Chief Operating Officer and Executive Member of the Board of Directors from 1996 to 2000. Dr. Garnier is a director of Radius Health, Inc. and Chairman of the Board of Alzheon, Inc. (non-public). He served as Chairman of NormOxys, Inc. (biopharmaceuticals) and as a director of Renault S.A. He serves on the Advisory Board of the Newman’s Own Foundation and is a former board member of the Stanford Advisory Council on Interdisciplinary Biosciences, Weill Cornell Medical College and the Dubai International Capital Advisory Board. In 2009, he was made a Knight Commander of the British Empire and in 2007 was named Officier de la Légion d’Honneur of France.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Awards, USD 305,000
Long-Term Incentive Plans, USD --
All Other, USD 1,107
Fiscal Year Total, USD 306,107

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gregory Hayes

15,831,300

Akhil Johri

5,095,030

David Gitlin

--

Robert Leduc

5,663,920

Robert McDonough

6,516,920

Elizabeth Amato

--
As Of  30 Dec 2016